Page last updated: 2024-08-21

abietic acid and luteolin

abietic acid has been researched along with luteolin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Bohlin, L; Huss, U; Perera, P; Ringbom, T; Vasänge, M1
Chang, JS; Jeong, HJ; Kim, D; Kim, JH; Kim, YM; Lee, WS; Nguyen, TT; Park, JY; Park, KH; Park, SJ; Rho, MC; Ryu, YB1
Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW1

Other Studies

3 other study(ies) available for abietic acid and luteolin

ArticleYear
Screening of ubiquitous plant constituents for COX-2 inhibition with a scintillation proximity based assay.
    Journal of natural products, 2002, Volume: 65, Issue:11

    Topics: Acrolein; Alkaloids; Animals; Anthraquinones; Aspirin; Biological Assay; Catalysis; Cinnamomum zeylanicum; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Eugenol; Flavonoids; Indomethacin; Inhibitory Concentration 50; Isoenzymes; Kinetics; Lactones; Models, Molecular; Nitrobenzenes; Oleanolic Acid; Plants, Medicinal; Prostaglandin-Endoperoxide Synthases; Pyrogallol; Steroids; Sulfonamides; Sulfones; Syzygium; Terpenes; Triterpenes; Ursolic Acid

2002
Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition.
    Bioorganic & medicinal chemistry, 2010, Nov-15, Volume: 18, Issue:22

    Topics: Apigenin; Biflavonoids; Binding Sites; Catalytic Domain; Computer Simulation; Coronavirus 3C Proteases; Cysteine Endopeptidases; Fluorescence Resonance Energy Transfer; Luteolin; Plant Leaves; Protease Inhibitors; Quercetin; Severe acute respiratory syndrome-related coronavirus; Structure-Activity Relationship; Taxaceae; Viral Proteins

2010
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
    Journal of medicinal chemistry, 2021, 12-09, Volume: 64, Issue:23

    Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors

2021